SCHEMBL8800029

SCHEMBL8800029

CCOC(=O)C(CCCNC(=O)OC(C)(C)C)(OCc1ccccn1)C(=O)OCC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.42
NFE2L2 Q16236 1/20 0.42
CYP3A4 P08684 1/20 0.40
CA12 O43570 4/20 0.40
CA1 P00915 4/20 0.40
CA2 P00918 4/20 0.40
CA9 Q16790 4/20 0.40
IDO1 P14902 1/20 0.40
NPC1 O15118 1/20 0.40
LMNA P02545 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
KDM4E B2RXH2 4/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
PTPRB P23467 1/20 0.39
POLB P06746 1/20 0.39
DRD2 P14416 2/20 0.38
MAPT P10636 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8329540 0.85 IDO1 (0.50) CYP3A4IDO1LMNASMN1; SMN2L3MBTL1
SCHEMBL8799761 0.83 CYP3A4 (0.44) KEAP1NFE2L2CYP3A4CA12CA1
SCHEMBL8798754 0.82 CYP3A4 (0.57) CYP3A4IDO1RAB9AKDM4EL3MBTL1
SCHEMBL8803281 0.80 HDAC3 (0.51) CYP3A4CA1CA2IDO1LMNA
SCHEMBL8799056 0.79 SIGMAR1 (0.51) CYP3A4CA1CA2IDO1LMNA
SCHEMBL8800040 0.78 LTA4H (0.42) NPC1LMNARAB9ASMN1; SMN2KDM4E
SCHEMBL8633540 0.78 IDO1 (0.46) CA12CA1CA2CA9IDO1
SCHEMBL8798252 0.77 CYP3A4 (0.56) CYP3A4IDO1PTPRB
SCHEMBL8799915 0.77 CA1 (0.45) CYP3A4CA12CA1CA2CA9
SCHEMBL8799637 0.76 CYP3A4 (0.49) CYP3A4CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0792878-A2 Geminal carboxylic acids and esters thereof, pharmaceutical formulations containing them useful in the treatment of bone dysmetabolism Dompé S.P.A. (IT) 1997-09-03 EP disclosed